An engineering-medicine-data science collaboration aims to end terminal disease diagnoses for more than 100K Americans.
We start with a focus on biology.
Whether we are modeling or engineering cells and tissues, analyzing large datasets, developing new imaging technologies, or synthesizing novel biomaterials, the problem statement always starts with the biology underlying the system, therapy, or disease process.
Our co-location within the highly-ranked UVA School of Medicine and UVA Health System uniquely positions us to influence the future of healthcare. Our culture values and rewards collaboration, initiative, and the translation of basic advances to achieve clinical and real world impact. In all that we do, we value and strive for diversity and inclusion.
Biomechanics expert Professor Silvia Blemker is building a set of tools to rigorously examine sex as a biological variable in...
Highlighting the multipliers of research growth, including grants, fellowships and the recruitment of excellent faculty.
Poor timing of influenza vaccination campaigns leads to an increase in premature births, lower birth-weight babies and the need to...
Increase in total research expenditures since 2015
$ 12 M
Exceeding $12.4 million per year for the past three years in total research expenditures
Federally funded student training programs, including two NIH T32 Training Grants and an NSF REU
Years in a row that a graduating biomedical engineer was a "UVA Engineering Outstanding Student."